SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001116679-06-000622
Filing Date
2006-03-07
Accepted
2006-03-07 16:24:00
Documents
1
Period of Report
2006-03-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3050
  Complete submission text file 0001116679-06-000622.txt   4976
Mailing Address 345 PARK AVENUE 41ST FLOOR NEW YORK NY 10154
Business Address 345 PARK AVENUE 41ST FLOOR NEW YORK NY 10154 212-750-6700
BIOENVISION INC (Issuer) CIK: 0001028205 (see all company filings)

IRS No.: 113375915 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address BIOENVISION, INC. 509 MADISON AVE., SUITE 404 NEW YORK NY 10022
Business Address 212-318-6700
Griffith Hugh (Reporting) CIK: 0001296964 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31787 | Film No.: 06670426